Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMM

Immupharma (IMM)

Immupharma Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:IMM
DateTimeSourceHeadlineSymbolCompany
08/11/20237:04AMUK RegulatoryImmupharma PLC Directorate ChangeLSE:IMMImmupharma Plc
06/30/20238:12AMUK RegulatoryImmupharma PLC Result of AGMLSE:IMMImmupharma Plc
06/19/20237:02AMAlliance NewsAlliance NewsIN BRIEF: ImmuPharma to start next two phases of Lupuzor trialLSE:IMMImmupharma Plc
06/19/20232:00AMUK RegulatoryImmupharma PLC Lupuzor UpdateLSE:IMMImmupharma Plc
06/06/20232:00AMUK RegulatoryImmupharma PLC IMM RNS Posting of RA and Notice of AGM 30 June 23LSE:IMMImmupharma Plc
05/18/20237:12AMAlliance NewsAlliance NewsIN BRIEF: ImmuPharma rises on FDA feedback for neurological diseaseLSE:IMMImmupharma Plc
05/18/20235:38AMDow Jones NewsImmuPharma Shares Rise on Positive Guidance From US FDA for P140LSE:IMMImmupharma Plc
05/18/20232:00AMUK RegulatoryImmupharma PLC Positive Pre-IND meeting with FDALSE:IMMImmupharma Plc
05/11/20236:48AMAlliance NewsAlliance NewsIN BRIEF: ImmuPharma annual loss narrows as R&D spending reducedLSE:IMMImmupharma Plc
05/11/20232:00AMUK RegulatoryImmupharma PLC Final ResultsLSE:IMMImmupharma Plc
05/10/20238:56AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
04/19/202310:40AMAlliance NewsAlliance NewsIN BRIEF: ImmuPharma says US FDA confirms date for Lupuzor meetingLSE:IMMImmupharma Plc
04/19/20232:00AMUK RegulatoryImmupharma PLC Lupozor Update - FDA confirms Type-C meeting dateLSE:IMMImmupharma Plc
04/12/20236:27AMAlliance NewsAlliance NewsIN BRIEF: ImmuPharma shares up as FDA meeting for new drug confirmedLSE:IMMImmupharma Plc
04/12/20234:02AMDow Jones NewsImmuPharma Shares Jump as FDA Meeting Date Set for P140 Clinical ProgramLSE:IMMImmupharma Plc
04/12/20232:00AMUK RegulatoryImmupharma PLC CIDP P140 Clinical Program UpdateLSE:IMMImmupharma Plc
03/27/20235:32AMAlliance NewsAlliance NewsImmuPharma submits phase 2/3 protocol to US FDA for Lupuzor treatmentLSE:IMMImmupharma Plc
03/27/20234:23AMDow Jones NewsImmuPharma Shares Rise on Lupus Candidate FDA Trial SubmissionLSE:IMMImmupharma Plc
03/27/20232:00AMUK RegulatoryImmupharma PLC Lupuzor(TM) UpdateLSE:IMMImmupharma Plc
03/09/202311:35AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
03/06/20236:22AMAlliance NewsAlliance NewsImmuPharma signs 12-month deal with Orano for use of peptide techLSE:IMMImmupharma Plc
03/06/20232:00AMUK RegulatoryImmupharma PLC Collaboration with Orano on ImmuPharma PeptideLSE:IMMImmupharma Plc
02/06/20236:37AMAlliance NewsAlliance NewsImmuPharma agrees study design with Avion for lupus programme LupuzorLSE:IMMImmupharma Plc
02/06/20233:58AMDow Jones NewsImmuPharma Shares Rise After Lupuzor Trial ConfirmedLSE:IMMImmupharma Plc
02/06/20232:00AMUK RegulatoryImmupharma PLC Lupuzor(TM) UpdateLSE:IMMImmupharma Plc
01/27/202311:25AMUK RegulatoryImmupharma PLC TR-1: Notification of major holdingsLSE:IMMImmupharma Plc
01/04/202312:26PMUK RegulatoryImmupharma PLC TR-1: Notification of major holdingsLSE:IMMImmupharma Plc
01/04/202311:40AMUK RegulatoryImmupharma PLC Second Price Monitoring ExtnLSE:IMMImmupharma Plc
01/04/202311:35AMUK RegulatoryImmupharma PLC Price Monitoring ExtensionLSE:IMMImmupharma Plc
01/03/202311:58AMUK RegulatoryImmupharma PLC TR-1: Notification of major holdingsLSE:IMMImmupharma Plc
 Showing the most relevant articles for your search:LSE:IMM